Robert G Finizio

CIK 1532235 · CEO · last filed 2025-07-15

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$43.98M

Companies

3

Total Filings

31

Lifetime Open-Market Net

-$14.34M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ZVSA Director $0.20 $0 2 2025-07-15
ZyVersa Therapeutics, Inc. (ZVSAW) Delisted Director $0 1 2022-12-14
TXMD CEO 19,991,637 $2.20 $43.98M -$14.34M 25 2021-07-02

Recent Filings · Page 3 of 4

31 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2018-09-24 TXMD Mixed -$1.20M EDGAR
2018-09-10 TXMD Mixed -$1.13M EDGAR
2018-03-19 TXMD Grant (A) $0 EDGAR
2017-03-17 TXMD Grant (A) $0 EDGAR
2015-12-21 TXMD Grant (A) $0 EDGAR
2014-03-28 TXMD Sell (S) −982,053 -$6.58M EDGAR
2014-02-21 TXMD Sell (S) −50,000 -$308.7K EDGAR
2014-01-23 TXMD Sell (S) −50,000 -$285.2K EDGAR
2012-12-04 Grant (A) $0
2012-04-17 Grant (A) $0
Showing 2130 of 31
Page 3 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.